During the past decade, Colon and Rectal Surgery Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Colon and Rectal Surgery Associates" are "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials), "Colonic Diseases" (1 trials), "Colorectal Adenocarcinoma" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Colon and Rectal Surgery Associates" in a lesser frequency.

Most popular intervention types in "Colon and Rectal Surgery Associates" are "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Draw" (1 trials), "Blood draw (venipuncture)" (1 trials), "Cx601" (1 trials), "Darvadstrocel" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colon and Rectal Surgery Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Colon and Rectal Surgery Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Colon and Rectal Surgery Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Colon and Rectal Surgery Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".